IE801762L - Insulin-zinc crystals - Google Patents
Insulin-zinc crystalsInfo
- Publication number
- IE801762L IE801762L IE801762A IE176280A IE801762L IE 801762 L IE801762 L IE 801762L IE 801762 A IE801762 A IE 801762A IE 176280 A IE176280 A IE 176280A IE 801762 L IE801762 L IE 801762L
- Authority
- IE
- Ireland
- Prior art keywords
- insulin
- crystals
- zinc crystals
- rhombohedrally
- rhombohedrons
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1. A process for the structural transformation of rhombohedrally crystallized insulin, preferably of pig origin, having a 4-Zn structure to rhombohedrons having a 2-Zn structure, which comprises maintaining the crystals having a 4-Zn structure in an aqueous medium containing less than 6% of sodium chloride, the pH of which medium is adjusted to 4.5 to 6.0 and maintained stable by addition of a buffer, at a temperature ranging from room temperature to 45 degrees C until in a sample crystals of the 4-Zn structure are no longer present.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792933946 DE2933946A1 (en) | 1979-08-22 | 1979-08-22 | INSULIN CRYSTAL SUSPENSION AND METHOD FOR THEIR PRODUCTION. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE801762L true IE801762L (en) | 1981-03-22 |
| IE50188B1 IE50188B1 (en) | 1986-03-05 |
Family
ID=6079022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1762/80A IE50188B1 (en) | 1979-08-22 | 1980-08-21 | Insulin crystal suspension and process for the preparation thereof |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0025868B1 (en) |
| JP (1) | JPS5632412A (en) |
| AT (1) | ATE1281T1 (en) |
| AU (1) | AU539091B2 (en) |
| CA (1) | CA1155439A (en) |
| DE (2) | DE2933946A1 (en) |
| DK (1) | DK149347C (en) |
| ES (1) | ES8205752A1 (en) |
| GR (1) | GR69915B (en) |
| IE (1) | IE50188B1 (en) |
| IL (1) | IL60889A (en) |
| ZA (1) | ZA805152B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534488A (en) * | 1993-08-13 | 1996-07-09 | Eli Lilly And Company | Insulin formulation |
| YU18596A (en) * | 1995-03-31 | 1998-07-10 | Eli Lilly And Company | Analogous formulations of monomer insulin |
| DK0840748T3 (en) | 1995-07-25 | 2003-07-28 | Novartis Ag | Transforming growth factor beta crystals |
| DE69806362T2 (en) * | 1997-03-20 | 2003-01-30 | Novo Nordisk As | THERAPEUTIC POWDER FORMULA FOR PULMONARY APPLICATION, WHICH CONTAINS CRYSTALLINE INSULIN |
| DE102009001969A1 (en) | 2009-03-30 | 2010-10-07 | Robert Bosch Gmbh | sensor module |
| US20220064213A1 (en) * | 2019-01-10 | 2022-03-03 | Biocon Limited | Preparative crystallization of recombinant human insulin |
-
1979
- 1979-08-22 DE DE19792933946 patent/DE2933946A1/en not_active Withdrawn
-
1980
- 1980-08-14 ES ES494260A patent/ES8205752A1/en not_active Expired
- 1980-08-16 AT AT80104879T patent/ATE1281T1/en not_active IP Right Cessation
- 1980-08-16 EP EP80104879A patent/EP0025868B1/en not_active Expired
- 1980-08-16 DE DE8080104879T patent/DE3060628D1/en not_active Expired
- 1980-08-20 GR GR62708A patent/GR69915B/el unknown
- 1980-08-21 CA CA000358705A patent/CA1155439A/en not_active Expired
- 1980-08-21 ZA ZA00805152A patent/ZA805152B/en unknown
- 1980-08-21 AU AU61621/80A patent/AU539091B2/en not_active Ceased
- 1980-08-21 DK DK359380A patent/DK149347C/en not_active IP Right Cessation
- 1980-08-21 IE IE1762/80A patent/IE50188B1/en unknown
- 1980-08-21 IL IL60889A patent/IL60889A/en unknown
- 1980-08-22 JP JP11487980A patent/JPS5632412A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU539091B2 (en) | 1984-09-13 |
| DE2933946A1 (en) | 1981-03-12 |
| IL60889A (en) | 1983-07-31 |
| CA1155439A (en) | 1983-10-18 |
| GR69915B (en) | 1982-07-21 |
| IL60889A0 (en) | 1980-10-26 |
| IE50188B1 (en) | 1986-03-05 |
| EP0025868B1 (en) | 1982-06-30 |
| DE3060628D1 (en) | 1982-08-19 |
| JPS5632412A (en) | 1981-04-01 |
| ES494260A0 (en) | 1982-08-01 |
| EP0025868A1 (en) | 1981-04-01 |
| ES8205752A1 (en) | 1982-08-01 |
| DK149347B (en) | 1986-05-12 |
| ZA805152B (en) | 1981-08-26 |
| DK359380A (en) | 1981-02-23 |
| ATE1281T1 (en) | 1982-07-15 |
| AU6162180A (en) | 1981-04-09 |
| DK149347C (en) | 1986-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH22646A (en) | Method of enhacing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicyloalkanes | |
| HU9301182D0 (en) | Method for producing fluoro-phenicole, its analogues and intermediary compounds | |
| DE69116791D1 (en) | Lactoneotrehalose, and their production and use | |
| NO301830B1 (en) | Crystalline lactitol, as well as the method of preparation and use thereof | |
| UA7088A1 (en) | Process for praparation of salt of 2-(2-hydroxyetoxy)ethylamine and 3,6-dichloro-2-metoxbenzoic acid | |
| IE801762L (en) | Insulin-zinc crystals | |
| ES480721A1 (en) | Lithium pseudomonate, process for its isolation and its hydrolysis. | |
| YU242787A (en) | Process for obtaining crystalline cephadroxyl monohydrate | |
| KR920008058A (en) | Solid lactulose | |
| AU565492B2 (en) | 4-phenyl-4-oxo-buten-2-oic acids | |
| HUT39329A (en) | Compound hindering formation of pollen consisting as reagent derivatives of pirazol and process for production of the reagent | |
| GB1520160A (en) | Process for producing sodium fluoride from sodium silicofluoride | |
| KR840007875A (en) | Method for preparing N- (3-trifluoromethylphenyl) -N'-propargyl piperazine | |
| ES8506689A1 (en) | Cumalincarboxylic-acid esters, process for their preparation and agricultural fungicides. | |
| SU1681500A1 (en) | METHOD OF SYNTHESIS OF P-SUBSTITUTED DERIVATIVES OF α-PHENOXYPROPIONIC ACID | |
| NAZAROV et al. | Quality of water reclaimed from urine as related to pH of initial product | |
| JPS56108800A (en) | Novel estradiol derivative, and antitumor agent containing the same | |
| SU1743148A1 (en) | Method of nitrilotriacetic acid synthesis | |
| GB902609A (en) | Process for the preparation of gluconic acid monohydrate | |
| ES8502110A1 (en) | Prodn. of tetra:acetyl di:pyridamol | |
| KR870010062A (en) | Method for preparing cephalosporin derivative | |
| SU1387350A1 (en) | METHOD OF STABILIZATION OF METHYLENE CHLORIDE | |
| JPS54145638A (en) | Novel derivative of xk-62-2 | |
| SU1538476A1 (en) | Method of benfothiamine synthesis | |
| JPS6483518A (en) | Basic crystallized zirconia-based sol |